← Eichor
Study identifier: NCT06267859 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Development of Methods for Effective Treatment and Improvement of Common Somatic Diseases in Children

Condition: Respiratory Diseases · Congenital Heart Defects  ·  Sponsor: Tashkent State Medical University (Tashkent Pediatric Medical Institute), Uzbekistan

PhaseEARLY_Phase 1
Planned participants110
Who can joinAll sexes, 3 Days to 15 Years
Healthy volunteersNo

About this study

The goal of the clinical study is to clarify the course of common congenital, infectious, and non-infectious diseases in children living in Uzbekistan, and to develop methods for their treatment and rehabilitation. The main questions it aims to answer: * Analysis of common congenital diseases among children; * Analysis of commonly diagnosed bronchopulmonary and cardiovascular diseases among children; * Based on the results of the primary research, common diseases among children will be identified; * Analysis of existing treatment methods and their effectiveness; * Development of modern methods of treatment and rehabilitation of children.

This description comes directly from the study's public registry record.

Talk to the study team

Shokhida T Turdieva, DSc  ·  +998935872570  ·  Shohidahon69@mail.ru

Kholida B Abdurashidova  ·  +998935092934  ·  otdel.nayka@mail.ru

Always discuss trial participation with your own doctor first.

Locations (1)

Turdieva Shokhida TolkunovnaTashkent, Yunus-obad District, UzbekistanRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06267859